Scientific Beta Multi-Beta Multi-Strategy (MBMS) indices outperform cap-weighted indices over a three-year live period by over 2% on average
The Scientific Beta Multi-Beta Multi-Strategy Equal Weight (EW) and Equal Risk Contribution (ERC) flagship indices in all regions have posted positive live performance in comparison with their cap-weighted counterparts, with an average annualised outperformance of 2.13% over the period since the indices went live on December 20, 2013 to the end of December 2016.
Over the three-year live period, the 18 indices that correspond to the initial flagship offering (i.e. the Scientific Beta Multi-Beta Multi-Strategy EW and ERC indices for nine regions: Developed, Developed ex US, Developed ex UK, Developed Europe ex UK, US, UK, Eurozone, Asia-Pacific ex Japan and Japan) all outperformed, with an average annualised excess return of 2.13%%. The Developed World indices for the EW and ERC indices produced excess returns of 1.61% and 1.65% respectively.
In terms of risk, the average reduction in volatility for the 18 flagship Scientific Beta indices was 9.40%. On average, we were able to measure an improvement in risk-adjusted performance, expressed by the Sharpe ratio, of 41.35% compared to the broad cap-weighted index. The Developed World indices for the EW and ERC indices produced improvements in Sharpe ratios of 45.19% and 44.34% respectively.
The Scientific Beta Multi-Beta Multi-Strategy flagship offering aims to offer very robust performance of smart beta indices in relation to their cap-weighted counterparts in all market conditions.
This robustness is due to a double layer of factor and specific risk diversification, which enables each of the smart factor indices that make up the Multi-Beta Multi-Strategy benchmark to benefit over the long term not only from diversified exposure to the rewarded risk factors that they represent (Value, Size, Momentum, Low Volatility) but also a strong reduction in non-rewarded idiosyncratic volatility that is often very significant in traditional factor indices, which tend to be highly concentrated and poorly diversified.
As part of its policy of transferring know-how to the industry, EDHEC-Risk Institute has set up ERI Scientific Beta. ERI Scientific Beta is an original initiative which aims to favour the adoption of the latest advances in smart beta design and implementation by the whole investment industry. Its academic origin provides the foundation for its strategy: offer, in the best economic conditions possible, the smart beta solutions that are most proven scientifically with full transparency of both the methods and the associated risks.
ERI Scientific Beta, 1 George Street, #07-02, Singapore 049145. For further information, please contact: [email protected], Web: www.scientificbeta.com.
Attachments:
http://www.globenewswire.com/NewsRoom/AttachmentNg/c513052a-490f-40a0-9fd3-8fa4e29ce92a


CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Apple Turns 50: From Garage Startup to AI Crossroads
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore 



